跳至主要内容
临床试验/NL-OMON55198
NL-OMON55198已完成不适用

Comparison of cooled versus conventional radiofrequency treatment of the genicular nerves for chronic knee pain: a multicentre randomised controlled non-inferiority pilot trial - Cocogen trial

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age >= 18 years
  • - Able to understand the informed consent form and provide written informed
  • consent and able to complete outcome measures.
  • - Chronic anterior knee pain (> 12 months) with an NRS > 4 on most or all days
  • for the index knee either constantly or with motion.
  • - Unresponsive to conventional treatments continued during 12 months including
  • physiotherapy, oral analgesics or intra-articular infiltrations.
  • - Radiologic confirmation of arthritis of OA grade of 2 (mild), 3 (moderate)
  • or 4 (severe) noted within 6 months for the index knee according the Kellgren
  • Lawrence criteria (27) diagnosed by an independent radiologist with experience
  • in musculoskeletal imaging on Rx or MRI or patients with total knee
  • arthroplasty of the index knee with a negative orthopaedic workout.
  • - Other therapies (including surgical interventions) for pain in the index
  • knee are allowed for the period of the study follow up as long as they are
  • documented. This is necessary to correctly estimate the costs in the cost
  • effectiveness analyses. Allowing patients to receive additional treatments will
  • also improve the protocol compliance.
  • - Agree to provide informed consent and to comply with the requirements of
  • this protocol for the full duration of the study

排除标准

  • - Patient refusal to comply to protocol procedures or schedule
  • - Local or systemic infection (bacteraemia)
  • - Evidence of inflammatory arthritis or an inflammatory systemic disease
  • responsible for knee pain
  • - Intra-articular injections (steroids, hyaluronic acid, platelet enriched
  • plasma, *) in the index knee during the 3 months prior to procedure
  • - Body mass index (BMI) > 40 kg/m2
  • - Pregnant, nursing or planning to become pregnant
  • - Chronic widespread pain
  • - Patients with psychosocial dysfunction will be referred for further
  • psychological follow up prior to possible inclusion
  • - Allergies to products used during the procedure
  • - Uncontrolled coagulopathy defined as supratherapeutic dose of
  • anticoagulation medication.
  • - Uncontrolled immune suppression
  • - Participating in another clinical trial/investigation within 30 days prior
  • to signing informed consent
  • - Patient is currently implanted with a defibrillator, neuromodulator or other
  • electrical devices
  • - Radicular pain in index leg
  • - Patient received previous conventional or cooled radiofrequency of the index

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验

Comparison of cooled versus conventional... | 临床试验